A California-based company has raised tens of millions of dollars to support its mission of bringing an ecstasy-based therapy to...
Medicine
Dive Brief: Allogene Therapeutics, a leading developer of “off-the-shelf” cell therapies for cancer, will deprioritize two of its most advanced...
CRISPR specialist Intellia Therapeutics on Thursday said it will lay off about 15% of its workforce as it pauses some...
To build a new biotechnology startup, Alex Aravanis looked to the past. The former Illumina and Grail executive has spent...
Dive Brief: Canada’s health regulators have approved Pfizer’s gene therapy for hemophilia B, the company said Wednesday, making it the...
The Food and Drug Administration closed out 2023 with rejections of three drugmaker applications for first approval or expanded use,...
Dive Brief: Swiss pharmaceutical company Novartis has formed a new collaboration with partner Voyager Therapeutics, agreeing Tuesday to license one...
A non-addictive pain pill faces its definitive test, while study results in ALS, a rare heart disease and lung cancer...
Dive Brief: Sanofi will stop developing one of its top cancer drug prospects after the experimental treatment fell short in...
Dive Brief: Weeks after installing a new CEO, BioMarin Pharmaceutical is overhauling oversight of the company at the board level....